Articles
Share
03/24/2015

FDA Clears NeuroMetrix Wearable Technology for Over-the-Counter Use in Treatment of Chronic Pain

WALTHAM, Mass.–(BUSINESS WIRE)– NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its wearable technology for treatment of chronic pain received 510(k) clearance (K140333) from the U.S. Food and Drug Administration (FDA) for over-the-counter use.

Read More

Any Questions?

We're here for you.

Get in touch with us
or call 800.204.6577

Try Quell for yourself

It's risk free with our 60 day money back guarantee

Shop